🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 43% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

6.4 Gram(s) Serving Size
1 Servings
Other Combinations Product Type
43% Evidence Coverage

Supplement Facts — Evidence Check

32.5 mg (3.5% DV)
📊 Market median: 99.0mg (503 products) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 32.5mg UL 4000mg
6.5 mg (1.5% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 6.5mg
Sodium
15 mg (1% DV)
Potassium
35 mg (1% DV)
Instantized BCAA 2:1:1 Blend
2500 mg
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 1875mg
Alpha Amino Hydration Blend
875 mg

Other Ingredients

Natural & Artificial flavors Citric Acid Malic Acid Sucralose Sunflower Lecithin Acesulfame Potassium FD&C Red #40

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Sugar Free

Product Information

📋 Directions for Use

Suggested Use: Mix each serving (one packet) of Alpha Amino in 4-6 oz. of cold water, juice, or sports drink one to two times daily.

⚠️ Warnings & Precautions

Warning: This product is only intended to be consumed by healthy adults, 18 years of age or older.

Do not use this product if you are pregnant or nursing.

Before using this product, consult a licensed, qualified, health care professional. Immediately discontinue use and contact a medical doctor if you experience any adverse reaction to this product. Discontinue use 2 weeks prior to surgery. Do not exceed recommendations for suggested use. Use only as directed. Do not use if safety seal is broken or missing.

Keep out of reach of children.

Phenylketonurics: Contains phenylalanine.

The phenylketonurics notice is intended for people with the genetic disorder, phenylketonuria.

Allergen Warning: Contains tree nuts (coconut).

🧪 Formulation Notes

Phenylketonurics: Contains phenylalanine.

Alpha Amino does not contain aspartame.

0g sugar

Allergen Warning: Contains tree nuts (coconut).

Additional Information

Store in a cool, dry place to reduce risk of clumping.

Some settling of powder may occur during shipping and handling, which may affect density of powder. This product contains the servings indicated when measured exactly by weight.

Made in the U.S.A. using U.S. and imported ingredients and components.

104356

Hydration Recovery

Naturally & artificially flavored Sample

Product Details

UPC / SKU 8 42595 10001 3
DSLD Entry Date 2018-02-23
Product Type Other Combinations
Form Powder
Brand Cellucor
DSLD ID 82487
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →